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Background
A major goal of HIV vaccine research is to identify immu-
nogens that elicit broadly neutralizing antibodies
(bNAbs). Although many recombinant proteins have
been produced that replicate the structure of the envelope
protein, none has been able to consistently elicit bNAbs.
We now report a new method to identify envelope pro-
teins with rare mutations that improve the exposure of
neutralizing sites. These envelopes potentially represent a
new source of improved HIV vaccine antigens.
Methods
Plasma from 28 recent HIV infections were obtained and
swarms of HIV envelope genes were amplified by PCR and
cloned into an expression plasmid. Pseudovirions were
prepared from 24-48 clones per individual and analyzed
for infectivity. Subsets of 10 clones selected from each
individual were analyzed for sensitivity to neutralization
by HIV+ sera possessing bNAbs. Pairs of neutralization
sensitive and resistant envelope genes from selected indi-
viduals were sequenced and site directed mutagenesis was
carried out to identify specific amino acid residues that
correlated with neutralization sensitivity.
Results
Pairs of neutralization sensitive and resistant viruses, with
minimal sequence differences, were recovered from 7 of
28 individuals and selected for mutagenesis studies. Anal-
ysis of envelope variants from subject 108060 showed a
single mutation, Q655R in the C34 helix of gp41, adja-
cent to the MPER, conferred sensitivity to bNAbs in HIV+
sera, various neutralizing MAbs, CD4-IgG, and Fuzeon.
This mutation disrupted a previously unexplored hydro-
gen bonded ring structure and appears to stabilize the pre-
fusion hairpin intermediate of the 6 helix bundle required
for virus fusion. Using this method, we were able to map
a novel mutation in the V1/V2 domain of a different indi-
vidual that conferred sensitivity to bNAbs in HIV+ sera by
a distinct mechanism.
Conclusion
Swarm Analysis is a robust method that provides new
insight into neutralization sensitivity and promises to
provide a new source of vaccine immunogens.
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